Literature DB >> 170382

Myocardial localization of 99mTc-pyrophosphate without evidence of acute myocardial infarction.

J S Soin, J A Burdine, W Beal.   

Abstract

Localization of 99mTc-pyrophosphate in the cardiac region during routine bone scanning for metastatic tumor is discussed in two cases. Clinical information as well as electrocardiographic and serum enzyme studies did not reveal any evidence of acute myocardial injury. The cause of myocardial localization of the radiopharmaceutical is not clear in these cases.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 170382

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  5 in total

1.  Assessment of diagnostic value of technetium-99m pyrophosphate myocardial scintigraphy in 80 patients with possible acute myocardial infarction.

Authors:  W F Walsh; H B Karunaratne; L Resnekov; H R Fill; P V Harper
Journal:  Br Heart J       Date:  1977-09

Review 2.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

Review 3.  Acute myocardial infarction: clinical application of technetium 99m stannous pyrophosphate infarct scintigraphy.

Authors:  J A Werner; E H Botvinick; D M Shames; W W Parmley
Journal:  West J Med       Date:  1977-12

4.  Disappearance of soft tissue 99mTc diphosphonate activity following radiation therapy.

Authors:  L T Hill
Journal:  J Natl Med Assoc       Date:  1981-12       Impact factor: 1.798

5.  Use of 129caesium, 99Tcm stannous pyrophosphate, and a combination of the two in the assessment of myocardial infarction.

Authors:  S Walton; E Kafetzakis; R A Shields; H J Testa; D J Rowlands
Journal:  Br Heart J       Date:  1978-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.